Evidence map›Paper›PMID 18697745›Full record

ArticleThe Journal of biological chemistry2008

Prostaglandin E2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A.

Utako Yokoyama, Susumu Minamisawa, Hong Quan, Toru Akaike, Sayaka Suzuki, Meihua Jin, Qibin Jiao, Mayumi Watanabe, Koji Otsu, Shiho Iwasaki and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. High PGEScientifica · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. A novel role for PGEAmerican journal of physiology. Heart and circulatory physiology · 2023
    Article
  7. Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  8. Article
  9. EPAC in Vascular Smooth Muscle Cells.International journal of molecular sciences · 2020
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Molecular Mechanisms for Regulating Postnatal Ductus Arteriosus Closure.International journal of molecular sciences · 2018
    Review
  16. Review
  17. Article
  18. Article
  19. Epac activation inhibits IL-6-induced cardiac myocyte dysfunction.The journal of physiological sciences : JPS · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Utako YokoyamaCardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Susumu Minamisawa
Hong Quan
Toru Akaike
Sayaka Suzuki
Meihua Jin
Qibin Jiao
Mayumi Watanabe
Koji Otsu
Shiho Iwasaki
Shigeru Nishimaki
Motohiko Sato
Yoshihiro Ishikawa
Yokohama City University · JPCardiovascular Institute Hospital · JPWaseda University · JP

Funding

Catalytic activation of adenylyl cyclase type VR01GM067773 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ISHIKAWA, YOSHIHIRO · 2004 to 2007
$1.3M
NIGMS NIH HHS R01 GM067773
6 · The paper itself

Abstract

We have demonstrated that chronic stimulation of the prostaglandin E2-cAMP-dependent protein kinase A (PKA) signal pathway plays a critical role in intimal cushion formation in perinatal ductus arteriosus (DA) through promoting synthesis of hyaluronan. We hypothesized that Epac, a newly identified effector of cAMP, may play a role in intimal cushion formation (ICF) in the DA distinct from that of PKA. In the present study, we found that the levels of Epac1 and Epac2 mRNAs were significantly up-regulated in the rat DA during the perinatal period. A specific EP4 agonist, ONO-AE1-329, increased Rap1 activity in the presence of a PKA inhibitor, PKI-(14-22)-amide, in DA smooth muscle cells. 8-pCPT-2'-O-Me-cAMP (O-Me-cAMP), a cAMP analog selective to Epac activator, promoted migration of DA smooth muscle cells (SMC) in a dose-dependent manner. Adenovirus-mediated Epac1 or Epac2 gene transfer further enhanced O-Me-cAMP-induced cell migration, although the effect of Epac1 overexpression on cell migration was stronger than that of Epac2. In addition, transfection of small interfering RNAs for Epac1, but not Epac2, significantly inhibited serum-mediated migration of DA SMCs. In the presence of O-Me-cAMP, actin stress fibers were well organized with enhanced focal adhesion, and cell shape was widely expanded. Adenovirus-mediated Epac1, but not Epac2 gene transfer, induced prominent ICF in the rat DA explants when compared with those with green fluorescent protein gene transfer. The thickness of intimal cushion became significantly greater (1.98-fold) in Epac1-overexpressed DA. O-Me-cAMP did not change hyaluronan production, although it decreased proliferation of DA SMCs. The present study demonstrated that Epac, especially Epac1, plays an important role in promoting SMC migration and thereby ICF in the rat DA.

Indexed as

AdenoviridaeAnimalsCell MovementCyclic AMP-Dependent Protein KinasesDinoprostoneDose-Response Relationship, DrugDuctus ArteriosusGuanine Nucleotide Exchange FactorsModels, BiologicalMyocytes, Smooth MuscleRatsRats, WistarSignal TransductionCyclic AMP-Dependent Protein KinasesDinoprostoneGuanine Nucleotide Exchange FactorsRAPGEF3 protein, humanRapgef3 protein, ratRAPGEF4 protein, human

Identifiers

PMID18697745
PMCPMC2568928
OpenAlexW1977189130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.